Skip to main content
Premium Trial:

Request an Annual Quote

BIOVIA Biologics

Dassault Systemes BIOVIA (formerly Accelrys) has launched BIOVIA Biologics, a comprehensive data management and workflow solution that supports the discovery, optimization, and development of biotherapeutic candidates.

The release includes tools that help scientists manage, process, and understand high-volume candidate antibody sequence and cell line data; assess developabilty early, and customize workflows. It also supports sharing data and analysis results and reporting and offers cloud-based deployment options.  

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.